CANCER IMMUNOTHERAPY

Cancer immunotherapy goes trispecific

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

Original article

  1. Wu, L. et al. Trispecific antibodies enhance the therapeutic efficacy of tumour-directed T cells through T cell receptor co-stimulation. Nat. Cancer https://doi.org/10.1038/s43018-019-0004-z (2019)

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Alexandra Flemming.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Flemming, A. Cancer immunotherapy goes trispecific. Nat Rev Immunol 20, 4–5 (2020). https://doi.org/10.1038/s41577-019-0255-z

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing